| Structure |
Chemical Name |
CAS |
MF |
 |
Fulvestrant Impurity 12 |
|
|
|
|
Linagliptin Impurity 56 |
|
|
|
|
Linagliptin Impurity 61 |
|
|
 |
Ornidazole Impurity 16 |
1565482-62-3 |
C7H11ClN2O |
|
|
Oseltamivir Impurity 46 |
|
|
|
|
Oseltamivir Impurity 53 |
|
|
|
|
Palbociclib Impurity 66 |
|
|
 |
Peramivir Impurity 13 |
2641684-79-7 |
C13H27ClN4O3 |
|
|
Pimecrolimus Impurity 2 |
|
|
|
|
Rosuvastatin Impurity 81 |
|
|
|
|
Rosuvastatin Impurity 102 |
|
|
|
|
Tazobactam Impurity 14 |
|
|
|
|
Ticagrelor Impurity 124 |
|
|
|
|
Tofacitinib Impurity 113 |
|
|
|
|
Voriconazole Impurity 20 |
|
|
|
|
Carbocistein Impurity F |
|
|
|
|
Cilastatin EP Impurity B |
|
|
 |
Olaparib Impurity 14 |
2250242-62-5 |
C36H28F2N6O4 |
 |
Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide |
24683-26-9 |
C12H13NO5S |
 |
Sugammadex |
1378831-29-8 |
C6H10O3S2 |
 |
Petunidin 3-O-glucoside |
71991-88-3 |
C22H23O12+ |
 |
1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazine hydrochloride |
70918-74-0 |
C13H17ClN2O3 |
![[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenyl] 4-chlorobenzoate](/CAS/20180719/GIF/41859-56-7.gif) |
[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenyl] 4-chlorobenzoate |
41859-56-7 |
C22H17Cl2NO3 |
 |
N-(2,4-DICHLORO-5-HYDROXYPHENYL)ACETAMIDE |
67669-19-6 |
C8H7Cl2NO2 |
|
|
Brimonidine Impurity B |
|
|
|
|
Diquafosol Impurity C |
|
|
|
|
Bortezomib Impurity 19 |
|
|
|
|
Apixaban Impurity 40 |
|
|
|
|
Axitinib Impurity 3 |
|
|
|
|
Sofosbuvir Impurity 10 |
|
|
 |
Venlafaxine Impurity 10 |
1997279-63-6 |
C17H27NO2 |
|
|
Dapoxetine Impurity 3 |
|
|
|
|
Regorafenib Impurity 16 |
|
|
|
|
Topiroxostat Impurity 7 |
|
|
|
|
Tofacitinib Impurity 12 |
|
|
|
|
Ticagrelor Impurity 16 |
|
|
|
|
Ticagrelor Impurity 22 |
|
|
|
|
Milrinone Impurity 5 |
|
|
 |
Caspofungin Impurity 4 |
258510-40-6 |
C49H78N8O17 |
|
|
Canagliflozin Impurity 27 |
|
|
|
|
Loxoprofen Impurity 1 |
|
|
|
|
Febuxostat Impurity 54 |
|
|
|
|
Silodosin Impurity B |
|
|
|
|
Cefminox Sodium impurity F |
|
|
|
|
Clindamycin Impurity F |
|
|
|
|
Fasudil iMpurity D |
|
|
 |
2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
929540-41-0 |
C36H41CaFN2O5 |
|
|
Doxofylline iMpurity C |
|
|
 |
Puerarin-4'-O-β-D-glucopyranoside |
117047-08-2 |
C27H30O14 |
 |
N-Propyl-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one |
2512208-76-1 |
C15H21NO3 |
 |
4-Desmethyl 3-Methyl Vortioxetine Hydrochloride |
1293343-01-7 |
|
 |
OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS) |
104721-52-0 |
C18H20FN3O5 |
![4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]-benzeneacetic Acid](/CAS/20200119/GIF/CB24972787.gif) |
4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]-benzeneacetic Acid |
1365244-64-9 |
C13H13N3O3S |
 |
PEONIN CHLORIDE(SH) |
132-37-6 |
C28H33ClO16 |
 |
Telmisartan tert-Butyl Ester |
144702-26-1 |
C37H38N4O2 |
 |
Amido Ethyl Meloxicam (Meloxicam Impurity) |
881399-30-0 |
C16H17N3O4S2 |
![(S)-Ethyl 2-((3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl)pentanoate ,95%](/CAS/GIF/129970-98-5.gif) |
(S)-Ethyl 2-((3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl)pentanoate ,95% |
129970-98-5 |
C19H30N2O4 |
 |
4'-(Difluoromethoxy)acetanilide |
22236-11-9 |
C9H9F2NO2 |
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-28-2.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-28-2 |
C24H30ClN7O4S |
 |
N-carbaMoyl-2-Methyl benzene sulfonaMide |
39051-77-9 |
C8H10N2O3S |
 |
Capecitabin iMpurity |
71609-08-0 |
C9H12FN3O4 |
|
|
4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride) |
|
|
![2-(((3aS,4R,6S,6aR)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol](/CAS/20180702/GIF/CB23143889.gif) |
2-(((3aS,4R,6S,6aR)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
|
C17H27ClN4O4S |
 |
Clindamycin impurity |
198080-64-7 |
C18H32N2O5S |
|
|
Digoxin impurity |
|
|
|
|
Lamivudine impurity |
|
|
 |
Levothyroxine Sodium impurity |
27566-09-2 |
C14H21NO4 |
 |
Dexchlorpheniramine impurity |
73775-50-5 |
C12H15ClN2 |
 |
(S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide |
1384441-38-6 |
C21H22N2O7S |
 |
(1R,2S,3S)-Aprepitant |
172822-28-5 |
C23H21F7N4O3 |
|
|
(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole compound with 6-methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole (1:1) |
|
|
![6-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]-oxazin-3-one](/CAS/20180702/GIF/869478-11-5.gif) |
6-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]-oxazin-3-one |
869478-11-5 |
C17H16ClNO4 |
![ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/77549-94-1.gif) |
ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
77549-94-1 |
C22H26N2O2 |
|
|
Dolutegravir Impurity 2 |
|
|
 |
Lesinurad Impurity J |
1210330-64-5 |
C14H10BrN3O2S |
 |
2-CHLOROMETHYL-3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINE |
128430-66-0 |
C9H9ClF3NO |
 |
1-(2,3-EPOXYPROPYL)-2-METHYL-5-NITROIMIDAZOLE |
16773-52-7 |
C7H9N3O3 |
|
|
Bendamustine Related Impurity 12 |
|
|
|
|
Bendamustine Related Impurity 3 |
|
|
 |
Edoxaban Impurity 26 (1R,2S,4R) |
1255529-33-9 |
C21H30ClN5O5 |
 |
Ezetimibe Impurity 36 |
1809031-15-9 |
C39H46F2N2O5Si2 |
 |
Linagliptin Impurity 29 |
2074688-82-5 |
C58H58N16O6 |
 |
Methylprednisolone Acetate EP Impurity H |
1968-76-9 |
C24H32O4 |
|
|
Rivaroxaban Impurity 44 |
|
|
|
|
Sitafloxacin Impurity 3 |
|
|
|
|
Tenofovir Impurity 39 |
|
|
|
|
Ticagrelor Related Compound 82 |
|
|
|
|
Vonoprazan Impurity 20 |
|
|
![N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-1-piperazineacetamide](/CAS/20200331/GIF/1393717-45-7.gif) |
N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-1-piperazineacetamide |
1393717-45-7 |
C24H33N3O4 |
![methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(ethyl)carbamate](/CAS/20200331/GIF/1361570-27-5.gif) |
methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(ethyl)carbamate |
1361570-27-5 |
C21H21FN8O2 |
|
|
Cefathiamidine Impurity G |
|
|
|
|
Olaparib Impurity P |
|
|
|
|
Ozagrel Impurity 1 |
|
|
|
|
Pidotimod Impurity P |
|
|
|
|
Pitavastatin Impurity 11 |
|
|
|
|
Pramipexole Impurity 18 |
|
|
|
|
Tenofovir disoproxil Impurity 18 |
|
|
|
|
Tenofovir Impurity 50 |
|
|
 |
Darunavir |
1526916-57-3 |
C22H31N3O5S |
 |
(S)-3-(4-(2,5-dibromobenzyl)phenoxy)tetrahydrofuran |
|
C17H16Br2O2 |